European Pharmaceutical Review

SEPTEMBER 28, 2023

There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.

Manufacturing 91

Manufacturing Government Pharmaceutical manufacturing Pharmaceutical 91

PM360

NOVEMBER 14, 2023

In March of this year the three largest insulin manufacturers announced a dramatic reduction in the price of many commonly prescribed insulins and a monthly out-of-pocket (OOP) cap of $35 that went into effect in May. References: 1.

Retail 52

Retail Pharmaceutical manufacturing Sales Insurance 52

European Pharmaceutical Review

SEPTEMBER 26, 2022

The company explained that using the latest manufacturing technology will be a key objective at the Carrigtwohill site, particularly to help the aesthetics side of the business. Reducing the facilities carbon impact will also be supported by the expansion. Reducing the facilities carbon impact will also be supported by the expansion.

Manufacturing 89

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 89

European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.

Pharmaceutical manufacturing 92

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 92

PM360

JUNE 26, 2023

The end-to-end supply chain comprises material procurement, manufacturing, transportation, warehousing, and distribution. For pharmaceutical manufacturing, many of these processes are subject to good manufacturing practice (GxP) and oversight by regulatory bodies. Some suggest that the government should incentivize U.S.

Manufacturing 97

Manufacturing Pharmaceutical manufacturing Pharma Management 97

European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

Management 84

Management Food and Drug Administration Manufacturing Pharmaceutical manufacturing 84

pharmaphorum

AUGUST 4, 2022

For instance, in pharmaceutical manufacturing, mistakes in training can lead to contamination or waste, which can cause businesses unnecessary headaches. The sheer pressure on the pharmaceutical industry to innovate caused a surge of job roles in IT, research and development (R&D), sales, and marketing.

Recruitment 90

Recruitment Pharma Training Pharmaceutical manufacturing 90

Clarify Health

OCTOBER 26, 2021

Not Enrolled Given this historical backdrop, the FDA and leading biotech and pharmaceutical manufacturers have taken initiatives to ensure: representative clinical trial recruitment that reflects the broader US patient population and equitable access to therapies and vaccines.

Food and Drug Administration 52

Food and Drug Administration Recruitment Pharmaceutical manufacturing Medical 52

European Pharmaceutical Review

JULY 21, 2023

What are the top three supply-related challenges facing pharmaceutical manufacturers? While supply chain challenges became evident during the pandemic, several regions worldwide still face issues leading to product shortages. His efforts included bridging and coordinating activities with key government entities.

Pharmaceutical 97

Pharmaceutical Food and Drug Administration Transportation Manufacturing 97

European Pharmaceutical Review

AUGUST 17, 2022

Despite this toll, AMR has often been called the ‘silent pandemic’: 4 “AMR is sadly silent because it has not been discussed like other pandemics – and of course has been in the shadow of the COVID-19 pandemic in recent years,” commented Melissa Gong Mitchell, Secretariat Lead of the AMR Industry Alliance. Frontiers in Microbiology.

Manufacturing 93

Manufacturing Food and Drug Administration Management Pharmaceutical manufacturing 93

pharmaphorum

NOVEMBER 25, 2022

Marcello Cattani, country lead and president and managing director, Italy & Malta, at Sanofi, as well as president of Farmindustria, spoke next, expressing that he couldn’t have been happier to be in attendance for the occasion. Going beyond the standards of care; improving drug safety and efficacy.

Pharmaceutical 92

Pharmaceutical Manufacturing Medicine Competition 92

pharmaphorum

OCTOBER 26, 2022

The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We As a result, society and government bodies have not developed models and policies that adequately support the development of and access to rare disease drugs.”. About the author.

Patients 75

Patients Pharma Consulting Transportation 75

pharmaphorum

JANUARY 24, 2023

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. ” Image from the Association of the British Pharmaceutical Industry (ABPI). Notable examples include a pair of 10-year alliances with mRNA specialists Moderna and BioNTech.

Manufacturing 104

Manufacturing Medicine Government Pharmaceutical manufacturing 104

pharmaphorum

NOVEMBER 24, 2022

However, with cleanrooms-on-demand representing a feasible and accessible opportunity for those across pharmaceutical manufacturing, what are the key challenges in adoption and how can we expect the industry to overcome them to reap the rewards on offer? But with a single dedicated cleanroom environment costing around $2.5

Pharma 86

Pharma Pharmaceutical manufacturing Manufacturing Marketing 86

World of DTC Marketing

DECEMBER 10, 2020

Among the 25 worldwide companies that spend the most on research and development—all more than $5 billion a year—seven are pharmaceutical manufacturers, but eight are automobile or automobile-parts companies with profit margins under 10 percent. Amazon’s operating margin is under 5 percent.

Insurance 181

Insurance Pharma Manufacturing Retail 181

Pharmaceutical Technology

AUGUST 30, 2022

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Manufacturing 78

Manufacturing Marketing Pharma Distribution 78

pharmaphorum

SEPTEMBER 30, 2022

The move to component management has dramatic implications for pharmaceutical manufacturers. As a result, filings and other forms can be completed more quickly and accurately, leading to enhanced quality and regulatory compliance. He is a strong proponent of standards and data governance. Successful CCMS implementation.

Management 52

Management Pharmaceutical Marketing Electronics 52